ProPhase Labs, Inc.
PRPH
Rank in Stocks
#34079
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously... ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire processβfrom researching and developing to manufacturing, distributing, marketing, and sellingβa range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
Share Price
$0.005525
Last synced: 2026-11-09
Market Cap
$77.44K
Change (1 day)
-44.75%
Change (1 year)
-99.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ProPhase Labs, Inc. (PRPH)
Category
Healthcare
Operating Margin for ProPhase Labs, Inc. (PRPH)
Operating Margin as of November 2026 TTM: -498.73%
According to ProPhase Labs, Inc.'s latest financial reports, its current operating margin (TTM) is -498.73%. At the end of 2025 the company had an operating margin of -415.35%.
Operating Margin history for ProPhase Labs, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -498.73% | 20.07% |
| 2025 | -415.35% | -27.21% |
| 2024 | -570.59% | 1,071.64% |
| 2023 | -48.70% | -353.12% |
| 2022 | 19.24% | 55.16% |
| 2021 | 12.40% | -145.31% |
| 2020 | -27.37% | -16.55% |
| 2019 | -32.80% | 163.45% |
| 2018 | -12.45% | -69.21% |
| 2017 | -40.44% | 219.94% |
| 2016 | -12.64% | -27.31% |
| 2015 | -17.39% | -50.97% |
| 2014 | -35.47% | -2,236.75% |
| 2013 | 1.66% | -133.88% |
| 2012 | -4.90% | -68.77% |
| 2011 | -15.69% | -36.68% |
| 2010 | -24.78% | 24.77% |
| 2009 | -19.86% | -39.49% |
| 2008 | -32.82% | 300.24% |
| 2007 | -8.20% | 44.37% |
| 2006 | -5.68% | -202.34% |
| 2005 | 5.55% | 1,253.66% |
| 2004 | 0.41% | -73.20% |
| 2003 | 1.53% | -108.52% |
| 2002 | -17.96% | 938.15% |
| 2001 | -1.73% | -94.36% |
| 2000 | -30.65% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.04% |
DE
|
|
| 19.68% | -100.04% |
DE
|
|
| 13.26% | -100.03% |
JP
|
|
| 17.08% | -100.03% |
CH
|
|
| 14.92% | -100.03% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ProPhase Labs, Inc.'s operating margin
What is ProPhase Labs, Inc.'s operating margin?
ProPhase Labs, Inc.'s operating margin is -498.73%, as of Nov 2026.
What was ProPhase Labs, Inc.'s operating margin in 2025?
In 2025, ProPhase Labs, Inc.'s operating margin was -415.35%, compared with -570.59% in 2024.
How has ProPhase Labs, Inc.'s operating margin changed since 2020?
From 2020 to 2025, ProPhase Labs, Inc.'s operating margin was highest in 2022 (19.24%) and lowest in 2024 (-570.59%).
How does ProPhase Labs, Inc.'s operating margin compare with similar companies?
ProPhase Labs, Inc.'s operating margin (-498.73%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.